A study published in this month’s issue of the Journal of Alzheimer’s Disease, and published online ahead of print by the U.S. National Institute of Health, has found strong evidence to suggest that THC (tetrahydrocannabinol) may provide a treatment option for Alzheimer’s disease.
“The purpose of this study was to investigate the potential therapeutic qualities of Δ9-tetrahydrocannabinol (THC) with respect to slowing or halting the hallmark characteristics of Alzheimer’s disease”, claims the study’s researchers.
After incubated “N2a-variant amyloid-β protein precursor (AβPP) cells” with THC, researchers found that; “These sets of data strongly suggest that THC could be a potential therapeutiase through multiple functions and pathways.”
The study, which can be found by clicking here, was conducted by researchers at the University of South Florida and Thomas Jefferson University.
A separate study which was also recently e-published ahead of print by the National Institute of Health, has found that a naturally occurring cannabinoid may treat “neurodegenerative diseases, such as AD [Alzheimer’s disease].”